Disproportionality analysis of dermatologic adverse events associated with nirogacestat: Insights from the U.S. Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Disproportionality analysis of dermatologic adverse events associated with nirogacestat: Insights from the U.S. Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2025/12/14
投稿者	Ke, Jianhao; Mao, Hongfeng; Deng, Hui
組織名	Department of Dermatology, Shanghai Sixth People's Hospital Affiliated to;Shanghai Jiao Tong University School of Medicine, Shanghai, China.;Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital;Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes;Institute, Shanghai Clinical Center for Diabetes, Shanghai Key Laboratory of;Diabetes Mellitus, Shanghai, China.;Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic;address: hdeng@sjtu.edu.cn.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/41390125/